Skip to main content
. 2015 Nov;7(11):509–516. doi: 10.4103/1947-2714.170611

Figure 1.

Figure 1

Placebo-controlled, double-blind, randomized crossover pilot trial over a 10-week period investigating the effect of Caralluma fimbriata extract (CFE) vs placebo maltodextrin/cabbage leaf, in children and adolescents with Prader-Willi syndrome (PWS) (n = 15). Delta scores were calculated over a 4-week period for both CFE and placebo groups